ArticleFrontiers in oncology2025

Time tO last ChemotherApy and death in ovaRian cancEr patients: TO CARE/MITO 42 study, a retrospective analysis of italian MITO centers.

Giulia Scotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.